AbCellera Biologics, Inc. (ABCL)
13.78
+0.04
(+0.29%)
USD |
NASDAQ |
Oct 05, 16:00
13.91
+0.13
(+0.94%)
Pre-Market: 08:04
AbCellera Biologics Price to Book Value : 4.713 for Oct. 5, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 05, 2026 | 4.713 |
| October 02, 2026 | 4.700 |
| October 01, 2026 | 4.758 |
| September 30, 2026 | 4.990 |
| September 29, 2026 | 5.069 |
| September 28, 2026 | 4.761 |
| September 25, 2026 | 4.344 |
| September 24, 2026 | 4.327 |
| September 23, 2026 | 4.210 |
| September 22, 2026 | 4.327 |
| September 21, 2026 | 4.330 |
| September 18, 2026 | 4.320 |
| September 17, 2026 | 4.354 |
| September 16, 2026 | 3.992 |
| September 15, 2026 | 3.903 |
| September 14, 2026 | 3.820 |
| September 11, 2026 | 3.725 |
| September 10, 2026 | 3.578 |
| September 09, 2026 | 3.780 |
| September 08, 2026 | 3.913 |
| September 04, 2026 | 3.910 |
| September 03, 2026 | 3.957 |
| September 02, 2026 | 3.886 |
| September 01, 2026 | 3.858 |
| August 31, 2026 | 3.927 |
| Date | Value |
|---|---|
| August 28, 2026 | 3.882 |
| August 27, 2026 | 4.241 |
| August 26, 2026 | 4.186 |
| August 25, 2026 | 4.275 |
| August 24, 2026 | 3.629 |
| August 21, 2026 | 3.872 |
| August 20, 2026 | 3.957 |
| August 19, 2026 | 4.108 |
| August 18, 2026 | 3.803 |
| August 17, 2026 | 3.831 |
| August 14, 2026 | 3.892 |
| August 13, 2026 | 3.752 |
| August 12, 2026 | 3.542 |
| August 11, 2026 | 3.338 |
| August 10, 2026 | 3.195 |
| August 07, 2026 | 2.370 |
| August 06, 2026 | 2.234 |
| August 05, 2026 | 2.025 |
| August 04, 2026 | 2.083 |
| August 03, 2026 | 1.994 |
| July 31, 2026 | 1.953 |
| July 30, 2026 | 1.946 |
| July 29, 2026 | 1.844 |
| July 28, 2026 | 1.809 |
| July 27, 2026 | 1.796 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| MindWalk Holdings Corp. | 14.21 |
| Repligen Corp. | 5.063 |
| Bio-Techne Corp. | 5.374 |
| Aurinia Pharmaceuticals, Inc. | 3.398 |
| BioLife Solutions, Inc. | 4.494 |
Price to Book Value Related Metrics
| PS Ratio | 62.89 |
| Price | 13.78 |
| Earnings Yield | -3.95% |
| Market Cap | 4.223B |